Drug Profile
Research programme: skin disorder therapeutics - I2DEAL
Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator I2DEAL
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Skin disorders
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for research development in Skin-disorders in Denmark
- 16 Jul 2016 No recent reports of development identified for research development in Skin-disorders in Germany
- 03 Oct 2012 Early research in Skin disorders in Denmark (unspecified route)